APA

Slovak M. L., Gundacker H., Bloomfield C. D., Dewald G., Appelbaum F. R., Larson R. A., Tallman M. S., Bennett J. M., Stirewalt D. L., Meshinchi S., Willman C. L., Ravindranath Y., Alonzo T. A., Carroll A. J., Raimondi S. C. & Heerema N. A. (20070926). A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies. : Leukemia.

Chicago

Slovak M L, Gundacker H, Bloomfield C D, Dewald G, Appelbaum F R, Larson R A, Tallman M S, Bennett J M, Stirewalt D L, Meshinchi S, Willman C L, Ravindranath Y, Alonzo T A, Carroll A J, Raimondi S C and Heerema N A. 20070926. A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies. : Leukemia.

Harvard

Slovak M. L., Gundacker H., Bloomfield C. D., Dewald G., Appelbaum F. R., Larson R. A., Tallman M. S., Bennett J. M., Stirewalt D. L., Meshinchi S., Willman C. L., Ravindranath Y., Alonzo T. A., Carroll A. J., Raimondi S. C. and Heerema N. A. (20070926). A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies. : Leukemia.

MLA

Slovak M L, Gundacker H, Bloomfield C D, Dewald G, Appelbaum F R, Larson R A, Tallman M S, Bennett J M, Stirewalt D L, Meshinchi S, Willman C L, Ravindranath Y, Alonzo T A, Carroll A J, Raimondi S C and Heerema N A. A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies. : Leukemia. 20070926.